Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-008323
Filing Date
2025-01-23
Accepted
2025-01-23 16:06:09
Documents
2
Period of Report
2025-01-13

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1635
2 EX-24 acet-ex24.htm EX-24 11714
  Complete submission text file 0000950170-25-008323.txt   14896
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ADICET BIO, INC. 131 DARTMOUTH STREET, 3RD FLOOR BOSTON, MA 02116
Business Address
Maltzman Julia D. (Reporting) CIK: 0002052749 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38359 | Film No.: 25550147